Literature DB >> 21458702

[International strategies and campaigns to promote the prudent use of antibiotics by health professionals and patients].

José Campos1, María Pérez-Vázquez, Jesús Oteo.   

Abstract

International agencies such as the World Health Organization (WHO), the European Union (EU), the European Centre for Disease Control and Prevention, and the U.S. Centers for Disease Control and Prevention have carried out various strategies to fight the emergency and spread of antimicrobial resistance. These strategies include surveillance of resistance and use, reduction of the disease burden through vaccination, and measures to control infection and to educate citizens and health professionals. Understanding of antibiotics among the general population is usually poor, so educational activities directed at the public and at health professionals are parts of the majority of campaigns to reduce inappropriate use of antibiotics. From 1990 to 2007, 22 large campaigns have been executed; in Spain, 2 national campaigns were launched in the autumn of 2006 and 2007 with the slogan, "Responsible use of antibiotics. Using them well today will protect us tomorrow". The EU and the WHO recommend the creation of interdisciplinary work groups, supported by the authorities, to promote the development of action plans and national strategies to combat antimicrobial resistance. To be effective, the national campaigns for prudent use of antibiotics should be continuous and carried out within a national strategy for improving the use of antimicrobials.
Copyright © 2010 Elsevier España S.L. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21458702     DOI: 10.1016/S0213-005X(10)70044-6

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  1 in total

1.  Factors determining antibiotic use in the general population: A qualitative study in Spain.

Authors:  Olalla Vazquez-Cancela; Laura Souto-Lopez; Juan M Vazquez-Lago; Ana Lopez; Adolfo Figueiras
Journal:  PLoS One       Date:  2021-02-04       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.